ArticleAmerican journal of cancer research2024

Efficacy of abiraterone combined with prednisone in castration-resistant prostate cancer and its impact on miR-221/222 expression.

Bingxin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.